[
    [
        {
            "time": "",
            "original_text": "H,P,V,概,念,股,成,绩,单：,沃,森,生,物,营,利,增,幅,最,快，,神,州,细,胞,研,发,费,最,多",
            "features": {
                "keywords": [
                    "沃森生物",
                    "神州细胞",
                    "营利增幅最快",
                    "研发费最多",
                    "HPV概念"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "HPV概念股"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "H,P,V,概,念,股,成,绩,单：,沃,森,生,物,营,利,增,幅,最,快，,神,州,细,胞,研,发,费,最,多",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        }
    ]
]